ATORVASTATIN REDUCES ENA-78 CHEMOKINE CONCENTRATIONS INDEPENDENT OF LDL-C CHANGES IN A CARDIOVASCULAR DISEASE FREE POPULATION.

被引：0
|
作者：
Welder, G. J. [1 ]
Schofield, R. S. [2 ]
Zineh, I. [1 ]
机构：
[1] Univ Florida, Dept Pharm Practice, Gainesville, FL USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 13 条
  • [1] ATORVASTATIN REDUCES ENA-78 CHEMOKINE CONCENTRATIONS INDEPENDENT OF LDL-C CHANGES IN A CARDIOVASCULAR DISEASE FREE POPULATION.
    Welder, G. J.
    Schofield, R. S.
    Zineh, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S4 - S4
  • [2] The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease
    ZGraggen, K
    Walz, A
    Mazzucchelli, L
    Strieter, RM
    Mueller, C
    GASTROENTEROLOGY, 1997, 113 (03) : 808 - 816
  • [3] MODELING THE POPULATION HEALTH BENEFITS OF LDL-C REDUCTION WITH ALIROCUMAB AMONG CARDIOVASCULAR DISEASE/HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH ELEVATED LDL-C
    Sanchez, R.
    Nasir, K.
    Klimchak, A.
    Kuznik, A.
    Joulain, F.
    Briggs, A.
    ATHEROSCLEROSIS, 2018, 275 : E100 - E100
  • [4] The ApoB/LDL-C Ratio Predicts Major Cardiovascular Events in Cardiovascular Disease Patients Independent of Type 2 Diabetes Status
    Larcher, Barbara
    Maechler, Maximilian
    Sprenger, Lukas
    Mader, Arthur
    Vonbank, Alexander
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2023, 72
  • [5] THE APOB/LDL-C RATIO PREDICTS MAJOR CARDIOVASCULAR EVENTS IN CARDIOVASCULAR DISEASE PATIENTS INDEPENDENT OF TYPE 2 DIABETES STATUS
    Larcher, Barbara
    Maechler, Maximilian
    Sprenger, Lukas
    Mader, Arthur
    Vonbank, Alexander
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2070 - 2070
  • [6] The ApoB/LDL-C Ratio Predicts Cardiovascular Events in Coronary Artery Disease Patients Independent of Type 2 Diabetes Status
    Larcher, Barbara
    Plattner, Thomas
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
  • [7] The ApoB/LDL-C ratio predicts cardiovascular events in coronary artery disease patients independent of type 2 diabetes status
    Larcher, B.
    Plattner, T.
    Mader, A.
    Vonbank, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [8] Daily almond consumption in cardiovascular disease prevention via LDL-C change in the US population: a cost-effectiveness analysis
    Wang Jifan
    Lee Bravatti, Michelle A.
    Johnson, Elizabeth J.
    Raman, Gowri
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [9] LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study
    Jukema, JW
    Liem, AH
    Dunselman, PHJM
    van der Sloot, JAP
    Lok, DJA
    Zwinderman, AH
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (11) : 1865 - 1874
  • [10] Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis
    Jifan Wang
    Michelle A. Lee Bravatti
    Elizabeth J. Johnson
    Gowri Raman
    BMC Public Health, 20
12